KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) FCF Margin (2016 - 2026)

Medtronic (MDT) has disclosed FCF Margin for 13 consecutive years, with 25.51% as the latest value for Q1 2026.

  • Quarterly FCF Margin rose 23.0% to 25.51% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 15.25% through Jan 2026, down 122.0% year-over-year, with the annual reading at 15.46% for FY2025, 61.0% down from the prior year.
  • FCF Margin hit 25.51% in Q1 2026 for Medtronic, up from 5.1% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 27.37% in Q2 2024 to a low of 2.51% in Q4 2023.
  • Historically, FCF Margin has averaged 15.51% across 5 years, with a median of 16.07% in 2023.
  • Biggest five-year swings in FCF Margin: plummeted -1119bps in 2022 and later skyrocketed 1023bps in 2024.
  • Year by year, FCF Margin stood at 7.9% in 2022, then tumbled by -68bps to 2.51% in 2023, then skyrocketed by 163bps to 6.59% in 2024, then decreased by -23bps to 5.1% in 2025, then surged by 400bps to 25.51% in 2026.
  • Business Quant data shows FCF Margin for MDT at 25.51% in Q1 2026, 5.1% in Q4 2025, and 6.81% in Q3 2025.